PQQ Benefits: What the Research Shows | telos rx
Woman running up stadium stairs outdoors, illustrating PQQ benefits research for mitochondrial energy
← Back to blog
longevity

PQQ Benefits: What the Research Shows for Mitochondria

By TelosRX Editorial Team

PQQ benefits look promising but early. Cell studies show it can spark new mitochondria, and small human trials report lower inflammation markers and better memory scores. TelosRX walks through what each study actually found, and what it didn't.

PQQ has a great marketing story. It's a compound that may help your cells build more mitochondria, the tiny engines that make your energy. That pitch sells a lot of capsules.

But what do the PQQ benefits look like in actual research? This review goes study by study. You'll see the design, the dose, the result, and the fine print for each one.

What Is PQQ?

PQQ stands for pyrroloquinoline quinone. It's a small molecule that acts as a redox cofactor, a helper that shuttles electrons in chemical reactions.

Bacteria use PQQ to make energy. Plants and animals pick it up from the environment and from food. Researchers have debated whether it should count as a vitamin. A 2021 review argued it acts like a "vitamin-like accessory factor" in mammals.

You get small amounts from foods like natto, green peppers, kiwi, parsley, tea, papaya, and spinach. Supplements deliver far more, usually 10 to 20 mg per day.

PQQ is sold as a dietary supplement. Supplements are not FDA-approved for safety or effectiveness before they reach shelves, and no PQQ product is approved for any medical use.

Why Mitochondria Matter Here

Mitochondria turn food and oxygen into ATP, your cells' energy currency. Their number and quality tend to decline with age and inactivity.

Your cells can build new mitochondria through a process called mitochondrial biogenesis. A master switch protein called PGC-1α (a gene regulator for energy metabolism) helps run it. Exercise is the best-known trigger.

PQQ caught researchers' attention because it seemed to flip that same switch. For the basics, see our explainer on mitochondrial biogenesis.

PQQ Research at a Glance

Study Who or what Dose and length Main finding Evidence level
Chowanadisai et al., 2010 Mouse liver cells 10–30 µM, 24–48 hours More mitochondria, via CREB and PGC-1α Preclinical
Harris et al., 2013 10 healthy adults, crossover 0.2–0.3 mg/kg, up to 76 hours Lower CRP and IL-6; urine markers shifted Small pilot
Hwang et al., 2020 23 untrained men 20 mg/day, 6 weeks plus training Higher PGC-1α; no fitness gain vs placebo Small RCT
Shiojima et al., 2022 64 adults aged 40–79 21.5 mg/day, 12 weeks Better memory and attention scores RCT, industry-linked
Tamakoshi et al., 2023 Adults aged 20–65 20 mg/day, 12 weeks Better memory scores RCT, industry-linked
Baltic et al., 2024 34 older adults with MCI PQQ plus hydrogen, 6 weeks Brain oxygenation and orientation improved Small RCT, combo product

Finding 1: PQQ Sparked New Mitochondria in Cell Studies

This is the study behind most PQQ marketing. Researchers exposed mouse liver cells to PQQ for 24 to 48 hours (Chowanadisai et al., 2010).

The cells showed more mitochondrial DNA, higher activity of key energy enzymes, and more oxygen use. PQQ worked by activating CREB and PGC-1α. When either was switched off, the effect disappeared.

  • Mitochondrial DNA content rose.
  • Citrate synthase and cytochrome c oxidase activity increased.
  • Cells were partly protected from several mitochondrial toxins.

The fine print: this was a dish of mouse cells. Cell results often don't carry over to people at realistic doses. It's a mechanism, not proof of a benefit.

Finding 2: Lower Inflammation Markers in a Small Human Study

The first human data came from the same research group. Ten healthy adults took PQQ in a fruit drink in two short experiments (Harris et al., 2013).

In the second experiment, they took 0.3 mg/kg daily. After 76 hours, researchers saw drops in C-reactive protein (CRP) and interleukin-6 (IL-6), two common inflammation markers. Urine metabolites shifted in a pattern the authors linked to mitochondrial activity.

Standard labs like cholesterol and glucose didn't change.

The fine print: ten people, a few days, and a simple crossover design. It's a useful signal that PQQ is absorbed and active in humans. It isn't evidence of long-term health effects.

Finding 3: Higher PGC-1α, but No Fitness Boost

This trial tested the big question: does PQQ add to exercise? Twenty-three untrained men took 20 mg of PQQ or a placebo daily. Both groups completed six weeks of supervised endurance training (Hwang et al., 2020).

Both groups got fitter. VO2peak and exercise test time improved in everyone. PQQ didn't add any extra performance or body-composition gain.

The PQQ group did show higher PGC-1α protein in muscle. That's the biogenesis signal from the cell studies, now seen in people.

The fine print: a biomarker moved, but outcomes you'd feel didn't. The trial was small and short. It suggests PQQ may support the machinery, but training did the real work.

Finding 4: Memory and Attention in Middle-Aged and Older Adults

This is the strongest human trial so far. It enrolled 64 healthy Japanese adults aged 40 to 79. They took 21.5 mg of PQQ disodium salt or a placebo daily for 12 weeks (Shiojima et al., 2022).

Fifty-eight finished. The PQQ group scored better than placebo on several computerized tests:

  • Composite and verbal memory
  • Reaction time and complex attention
  • Cognitive flexibility and executive function
  • Motor speed

Questionnaire scores for forgetfulness also improved. No adverse events were reported.

The fine print: several authors work for a PQQ supplier, and participants had self-reported forgetfulness. Independent replication would strengthen the case.

Finding 5: Similar Results in a Wider Age Range

A follow-up trial tested 20 mg per day for 12 weeks in adults aged 20 to 65 (Tamakoshi et al., 2023). After 12 weeks, the PQQ group improved on composite and verbal memory.

Results differed by age. Younger adults (20 to 40) improved on flexibility and processing speed by week 8. Older adults (41 to 65) improved on memory by week 12.

The fine print: most authors are employed by a PQQ manufacturer. The design was double-blind and placebo-controlled, which helps. Still, two industry-linked trials don't settle the question.

Finding 6: A PQQ Combination in Mild Cognitive Impairment

A 2024 trial tested a blend of PQQ and hydrogen-producing minerals. Thirty-four older adults with mild cognitive impairment (MCI) took it or a placebo twice daily for six weeks (Baltic et al., 2024).

  • Brain oxygen saturation rose from 48.4% to 52.8% in the active group.
  • Orientation scores on a dementia rating scale improved more than placebo.
  • BDNF (a brain growth factor) rose within the active group, but the difference versus placebo wasn't significant.
  • Brain N-acetyl aspartate, a marker of neuron health, rose in several regions.

The fine print: this was a combination product. You can't tell how much came from PQQ versus hydrogen. Six weeks and 34 people is a pilot-scale study.

What the Research Doesn't Show Yet

Here's where the evidence runs out. These gaps matter as much as the findings.

  • No long-term human trials. The longest studies run 12 weeks.
  • No hard outcomes. No trial shows PQQ changes disease rates, lifespan, or healthspan in people.
  • Small samples. The largest trial enrolled 64 people.
  • Industry ties. The cognitive trials were run or funded by PQQ makers.
  • No performance benefit. The one exercise trial found no fitness edge over training alone.
  • Limited diversity. Some studies enrolled only men or a single population.

Put simply, PQQ is interesting, plausible, and under-tested. Read bold marketing claims with healthy skepticism.

How PQQ Compares With Other Mitochondrial Compounds

PQQ is one of several compounds studied for mitochondrial support. They work at different points in the energy pathway.

Compound Main role How it's used Regulatory status
PQQ May signal new mitochondria via PGC-1α Oral supplement Dietary supplement
CoQ10 Carries electrons inside the energy chain Oral supplement Dietary supplement
NAD+ Coenzyme for energy and repair enzymes Oral precursors; compounded nasal or injectable forms Compounded forms are not FDA-approved
MOTS-c Mitochondria-derived peptide studied in metabolism Compounded injectable Not FDA-approved

Learn more in our guides to CoQ10 for mitochondrial health and how to improve mitochondrial function. Curious about peptides in this space? Read about MOTS-c at TelosRX, a mitochondria-derived peptide that is not FDA-approved and is still being studied.

Exploring mitochondrial support beyond supplements? See NAD+ nasal spray at TelosRX. Compounded NAD+ is not FDA-approved, and any prescription is subject to medical approval by a licensed provider.

How to Read PQQ Studies Like a Pharmacist

Supplement headlines often skip the details that matter. A few quick questions help you sort strong evidence from hype.

  1. Was it done in people? Cell and animal results are starting points, not proof.
  2. Was there a placebo group? Without one, expectation alone can shift results.
  3. How many people took part? Trials under 100 people can miss effects or find false ones.
  4. How long did it run? Weeks of data say little about years of use.
  5. What was measured? A blood marker moving isn't the same as feeling or functioning better.
  6. Who paid for it? Industry funding doesn't void a study, but independent replication matters.

Run the PQQ trials through that checklist and a pattern appears. The signals are consistent but early.

Who Might Consider PQQ, and Who Might Skip It

Based on current evidence, PQQ is a reasonable thing to discuss, not a must-have. Some people are more likely to be curious about it.

  • Middle-aged or older adults interested in memory and focus support
  • People already exercising who want to explore mitochondrial support
  • Anyone building a broader longevity routine with a clinician

On the other hand, you can probably skip it if you're hoping for a performance edge. The one exercise trial didn't find one. If budget is tight, sleep, training, and diet deliver more proven value per dollar.

PQQ Doses Used in Studies

There's no official recommended intake for PQQ. Human studies have used a fairly narrow range.

  • Short-term pilot: 0.2 to 0.3 mg per kg of body weight.
  • Exercise trial: 20 mg per day for six weeks.
  • Cognition trials: 20 to 21.5 mg per day for 12 weeks.

Most commercial products fall in the 10 to 20 mg range. Higher doses haven't shown extra benefit in people. More isn't automatically better.

Safety and Side Effects

The human trials reported few problems. The 12-week cognition study observed no adverse events. That's reassuring, but limited by short timelines and small groups.

Supplement references mention possible headache, drowsiness, and stomach upset. Long-term safety hasn't been studied.

Talk with a clinician before taking PQQ if any of these apply:

  • You're pregnant or breastfeeding, since safety data is lacking.
  • You have kidney or liver disease.
  • You take several medications or supplements.
  • You're scheduled for surgery.

Supplement quality also varies. Look for products with third-party testing, since supplements aren't reviewed by the FDA before sale.

Lifestyle Still Comes First

The exercise trial makes a quiet but important point. Training improved fitness in everyone. PQQ didn't add to it.

The most reliable mitochondrial boosters remain the unglamorous ones: regular aerobic exercise, strength work, good sleep, and a diet built on whole foods. Supplements, if used at all, sit on top of that foundation.

How TelosRX Works

TelosRX is an online-first, asynchronous telehealth service. You complete a secure intake on your own schedule. A licensed provider reviews your health history and goals, usually without a live appointment.

If a longevity therapy like NAD+ is appropriate, the provider may prescribe it. If not, they'll explain why and may suggest other options.

Frequently Asked Questions

What are the main PQQ benefits according to research?

Research suggests PQQ may support mitochondrial biogenesis, lower some inflammation markers, and improve memory and attention scores. The mitochondrial evidence comes mostly from cell studies plus one small human trial. The cognitive findings come from 12-week trials linked to PQQ makers. Long-term human outcomes haven't been studied.

Does PQQ really make new mitochondria?

In mouse cells, PQQ increased mitochondrial DNA and energy enzyme activity through the CREB and PGC-1α pathway. In a 2020 human trial, PQQ raised PGC-1α protein in muscle during endurance training. However, it didn't improve fitness beyond training alone. Direct proof of more mitochondria in humans is still limited.

How long does PQQ take to work?

Study timelines give a rough guide. Inflammation markers shifted within days in a small pilot study. Cognitive improvements appeared after 8 to 12 weeks in controlled trials. Individual responses vary, and many people may notice nothing. PQQ isn't a stimulant, so you shouldn't expect an immediate energy change.

Is it safe to take PQQ every day?

Daily doses of 20 to 21.5 mg were well tolerated in trials lasting up to 12 weeks. The largest trial reported no adverse events. Long-term safety hasn't been studied. People who are pregnant, breastfeeding, managing kidney or liver disease, or taking several medications should check with a clinician first.

Can you get enough PQQ from food?

Foods like natto, green peppers, kiwi, parsley, tea, papaya, and spinach contain PQQ, but in small amounts. Typical diets deliver far less than the 20 mg used in human trials. Whether those trial doses are needed for health benefits is still an open question, since no study has compared them with dietary intake.

Is PQQ better than CoQ10 or NAD+?

They aren't direct substitutes. CoQ10 carries electrons within the energy chain. NAD+ is a coenzyme for energy and repair enzymes. PQQ may signal cells to build new mitochondria. No head-to-head trials compare them. Your provider can help decide what fits your goals, health history, and lab results.

TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.

Start your private evaluation at TelosRX.

Related research

Compounded medications are compounded, not FDA-approved. Prescriptions are never automatic or guaranteed. TelosRX operates under LegitScript-certified telehealth standards as an online-first, asynchronous telehealth service.

Read more from TelosRX